animo – young flemish socialists - is deeply concerned with the recent developments in the pharmaceutical sector, where the European commission strives towards a minimal ruling in the sector. Gunter Verheugen, the European commissioner for Enterprise & Industry announced a couple of weeks ago that the pharmaceutical industry should be allowed to inform patients directly about their products, even for prescription drugs. The difference between informing and advertising, however, is paper thin and very easy to circumvent.
Directly informing the patients has disastrous consequences. Costs for marketing will take a bigger amount of the total revenue that in many drug companies has already risen up to 30%. This leads to more expensive drugs and valuable research&development money being lost. In the end this will lead to a struggle of the most commercial and not of the best fit of medicine. In addition, the knowledge and expertise of the doctors will be undermined , when a patient is confused through industrial “information” . The partially informed consumer will of course be held blind for possible adverse effects, all with the purpose of maximizing profit. Lastly, this is a perverse method to encourage the overall use of medicine. For example, advertising for foot mould medicine in Belgium has led to a multiplication of revenues (and nausea reactions) by five.
This commercialization of the pharmaceutical industry under the liberal impulse of this commissioner is once more a step in the wrong direction. animo stands up to turn the tide.
animo makes the following demands:
- Marketing directly from industry to patients must be forbidden, be they medicines with or without prescription
- Maximum expenditure of 7% of total revenue of a pharmaceutical company for sharing objective information towards healthcare personnel. Needed pharmaceutical funds need to be invested in research&development of new medicines and not in advertising





